National Healthcare Corp
NHCNYSECIK 1047335HealthcareFiscal year ends Dec 31
Reports and events: 272 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1114:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-026960 |
| 2026-08-1114:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026957 |
| 2026-08-0614:53 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-026199 |
| 2026-07-0116:43 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-022306 |
| 2026-05-2717:13 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-26-018604 |
| 2026-05-1516:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-017374 |
| 2026-05-1309:57 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-016571 |
| 2026-05-0811:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015802 |
| 2026-05-0716:28 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-015612 |
| 2026-05-0716:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-015606 |
| 2026-04-2218:46 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012953 |
| 2026-04-0216:31 ET | DEF 14A | Proxy statementPeriod 2026-05-07 | 0001140361-26-013005 |
| 2026-02-2709:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-006000 |
| 2026-02-2617:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-005910 |
| 2026-02-1710:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-004270 |
| 2026-02-1309:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-004009 |
| 2025-11-1216:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-034451 |
| 2025-11-0709:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-033736 |
| 2025-11-0709:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033734 |
| 2025-11-0616:39 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-033631 |
| 2025-09-2616:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029946 |
| 2025-09-1217:20 ET | 8-K | 8.01 Other events | 0001437749-25-028968 |
| 2025-08-0810:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025579 |
| 2025-08-0810:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-025577 |
| 2025-08-0717:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-025500 |
| 2025-05-1316:11 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-016458 |
| 2025-05-0909:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-015666 |
| 2025-05-0909:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-015664 |
| 2025-05-0816:13 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-015499 |
| 2025-04-0816:07 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-25-011399 |
| 2025-03-2816:36 ET | DEF 14A | Proxy statementPeriod 2025-05-08 | 0001140361-25-011007 |
| 2025-03-0316:33 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001437749-25-005928 |
| 2025-02-2815:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-005690 |
| 2025-02-2717:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-005510 |
| 2025-02-1809:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-004137 |
| 2024-11-1417:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-24-034983 |
| 2024-11-1209:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034376 |
| 2024-11-1209:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-034374 |
| 2024-11-0716:59 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-033970 |
| 2024-08-0910:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-025687 |
| 2024-08-0910:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-025685 |
| 2024-08-0817:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025603 |
| 2024-08-0615:50 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-024854 |
| 2024-07-1116:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-24-022577 |
| 2024-05-3117:25 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-018940 |
| 2024-05-1517:33 ET | 8-K | 5.07 Shareholder vote results | 0001437749-24-016722 |
| 2024-05-1010:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-015875 |
| 2024-05-1010:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-015872 |
| 2024-05-0917:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-015736 |
| 2024-04-0516:30 ET | DEF 14A | Proxy statementPeriod 2024-05-09 | 0001140361-24-018333 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 10:11 ET. Listed shows no prices and gives no investment advice.